Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Dako acquires Norwegian instruments firm

Dako acquires Norwegian instruments firm

4th September 2008

Dako has completed a deal for 100 per cent of the shares of Norwegian instrument development specialist InstrumenC, the company has announced.

Both parties have agreed not to disclose the financial details of agreement but the Danish cancer diagnostics developer said the purchase is part of its overall strategy to "improve workflow in pathology laboratories around the world".

The acquisition will allow Dako to integrate H&E staining, which is required for all tests done in pathology labs before a cancer diagnosis can be made, with the rest of its current service package.

Patrik Dahlen, the company’s chief executive officer, said the deal will also allow Dako to use InstrumenC technology in the development of its own "next generation" instruments, ultimately leading to faster, safer and more accurate cancer diagnostics for both hospitals and patients.

"InstrumeC has attracted attention in the sector for many years. This is why I am very pleased that we now will have such excellent skills and experience on board," he said.

Dako has production facilities in the United States and Denmark, as well as subsidiaries in 20 different countries and 50 national distributors.
ADNFCR-1050-ID-18763605-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.